Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Intravenous (IV) Solutions Market

Veterinary Intravenous (IV) Solutions Market Size

  • Report ID: GMI10452
  • Published Date: Jul 2024
  • Report Format: PDF

Veterinary Intravenous Solutions Market Size

Veterinary Intravenous Solutions Market accounted for USD 1.5 billion in 2023 and is anticipated to experience growth at 8% CAGR between 2024 and 2032. Advancements in veterinary medicine have greatly boosted the market. New IV fluid delivery systems, like specialized infusion pumps and fluid monitors, have made IV solution administration more efficient and safer. These technologies ensure accurate fluid delivery and reduce complications, supporting market growth.

 

Another key driver is the increase in pet adoption and spending on pet healthcare. As more people adopt pets, the demand for veterinary care, including IV therapy for health issues, surgeries, and critical care, grows. This trend shows a societal shift towards investing more in pet health?.
 

Veterinary IV solutions are sterile liquids given directly into an animal's bloodstream to treat medical conditions. They help restore hydration, balance electrolytes, and provide nutrients. These solutions are crucial for managing dehydration, shock, and during surgeries. Types include isotonic crystalloids, synthetic colloids, natural colloids, dextrose solutions, and parenteral nutrition. They are vital for maintaining blood volume, tissue perfusion, and supporting metabolic functions in both routine and critical care?.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global veterinary intravenous (IV) solutions industry was valued at USD 1.5 billion in 2023 and is anticipated to register 8% CAGR between 2024 and 2032, driven by advancements in veterinary medicine and increase in pet adoption and spending on pet healthcare.

The hospitals & clinics segment in the market is expected to reach USD 1.7 billion by 2032 due to high patient volumes, advanced equipment, and skilled staff driving IV therapy utilization.

North America veterinary intravenous solutions market is expected to reach USD 1.2 billion by 2032, fueled by the rising chronic diseases in pets requiring intensive IV management.

B. Braun Melsungen AG, Ceva Santé Animale, Dechra Pharmaceuticals plc, Elanco Animal Health, Fresenius Kabi, Hospira (Pfizer Inc.), Jorgensen Laboratories, LLC, Merck & Co. Inc., Sykes Vet International Pty Ltd., and Zoetis, Inc.

Veterinary Intravenous Solutions Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 276
  • Countries covered: 22
  • Pages: 155
 Download Free Sample